Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00919165 · ClinicalTrials.gov registry record

Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Placement

A clinical trial, sponsored by Corewell Health West.

Completed
Registry status
19
Enrollment target

NCT00919165: Completed study, sponsored by Corewell Health West.

NCT00919165 is a clinical trial that has completed, run by Corewell Health West. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00919165 has completed, sponsored by Corewell Health West.

COMPLETED
Registry status
19 participants
Enrollment target

Study Summary

To determine the effect of carotid artery stenting, on cognitive function, in patients with high grade carotid artery stenosis

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2007-12
Est. Completion 2017-04-20
Corewell Health West

38 total trials

What the finished NCT00919165 record still lists

NCT00919165 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00919165 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00919165 about?

NCT00919165 is a clinical study titled "Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Placement". To determine the effect of carotid artery stenting, on cognitive function, in patients with high grade carotid artery stenosis

What is the current status of trial NCT00919165?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2007-12. Estimated completion is 2017-04-20.

Who is sponsoring clinical trial NCT00919165?

This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00919165, the US trial registry maintained by the National Library of Medicine. NCT00919165 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.